ASH in a Flash – Race and Ancestry in Precision Medicine – Dr. Sant-Rayn Pasricha
Introducing #ASHinaFlash, your fast track to essential #ASH24 content! Get expert highlights of must-see sessions and quick takes on the latest #hematology b…
Introducing #ASHinaFlash, your fast track to essential #ASH24 content! Get expert highlights of must-see sessions and quick takes on the latest #hematology b…
Patients with subacute or chronic subdural hematoma frequently have a recurrence after surgery. The effect of adjunctive middle meningeal artery embolization…
The recent discovery of TSMC chips in Huawei devices has revealed some gaps in the US sanctions on China.Join the Patreon here: https://www.patreon.com/Peter…
During this live social media event, esteemed faculty will discuss the latest clinical updates on the treatment of patients with IBS-C. Watch LIVE to enhance…
David S. Miller, MD, discusses key efficacy, safety, and quality-adjusted survival data with selinexor in TP53 wild-type endometrial cancer.
A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.
IGV-001, an autologous cell immunotherapy, demonstrated an acceptable safety profile in patients with newly diagnosed glioblastoma.
A biologics license application was submitted to the FDA seeking the approval of RP1 plus nivolumab for patients with PD-1 inhibitor–exposed melanoma.
The NCI Cancer Research Data Commons has launched the Clinical and Translational Data Commons, a dedicated resource for NCI-funded clinical and translational data. Learn more…
At OHSU Knight Cancer Institute, patients are front of mind in drive toward cancer early detection, interventions.
Jack, a head and neck cancer (HNC) survivor, and his wife, Maryellen, share how they navigate mealtime, including dietary changes that have helped as Jack…